ArticleVirology journal2025
Two distinct polymorphisms in the basic region of Meq protein of marek's disease virus alter pathological progression and clinical manifestations.
Article in Virology journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Virulence of Marek's disease virus in Japan is linked to polymorphisms in theThe Journal of general virology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
backgroundMarek's disease virus (MDV) causes Marek's disease (MD) in chickens, which is characterized by malignant lymphomas and neurological disorders. Although MD is currently controlled using live vaccines, the virulence of field strains has continuously increased in recent decades. Polymorphisms in the MDV-encoded oncoprotein Meq are shared among field strains according to their virulence. In particular, very virulent MDV strains harbor characteristic amino acid changes in the basic region of Meq at positions 77 and 80; however, the contribution of these polymorphisms to virulence remains unclear.
methodsTo assess the impact of these polymorphisms on MDV virulence, we generated recombinant MDV (rMDV) based on the very virulent RB-1B strain, harboring K77E and D80Y substitutions in Meq found in low-virulent strains (rRB-1B_Meq77/80). Chickens were challenged with rMDVs, and survival rates and tumor incidence were evaluated. Viral loads in major organs were quantified by quantitative PCR, and the dynamics of MDV-infected cells and T cells were analyzed using flow cytometry. In addition, histopathological analysis was performed to further examine differences in pathogenesis in detail. To elucidate the mechanisms underlying pathogenesis, we conducted reporter assays to assess the effect of these polymorphisms in the basic region on its transcriptional regulatory activity.
resultsrRB-1B_Meq77/80 exhibited a reduced virulence but unexpectedly caused other clinical signs, including open-mouth breathing, in infected chickens. Quantitative PCR analysis showed consistently lower viral loads across all examined organs in rRB-1B_Meq77/80-infected chickens. Flow cytometric analysis revealed a reduction in MDV-infected cells, accompanied by a notable increase in CD8⁺ T cell populations. Histopathological analysis showed bronchus-associated lymphoid tissue hyperplasia in the lungs. Reporter assays revealed that most amino acid substitutions in the basic region in low-virulence strains reduced transcriptional regulatory activity.
conclusionOur data indicate that polymorphisms at positions 77 and 80 in the Meq of low-virulence strains reduce MDV virulence and Meq-mediated transcription and possibly alter pathogenesis. This study improves our understanding of the mechanisms underlying MDV virulence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.